---
$id: https://graph.org.ai/products/commodity/51171836
$type: Product
source: UNSPSC
code: "51171836"
title: "Cilansetron"
class: "51171800"
classTitle: "Antiemetics and antinauseants and antivertigo agents"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cilansetron

**UNSPSC Code**: 51171836
**Class**: [Antiemetics and antinauseants and antivertigo agents](Antiemetics and antinauseants and antivertigo agents.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a 5-ht3 receptor antagonist with the molecular formula C20H21N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2J6DQ1U5B5, chemically known as 4h-pyrido(3,2,1-jk)carbazol-11(8h)-one, 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-, (r)- but generally known as cilansetron, which bears US NIH Compound Identifier 65939. European Medicines Agency schedules Cilansetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06263MIG. The term CILANSETRON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). World Health Organization schedules cilansetron in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule cilansetron under HS 29332990 and SITC 51573. As of Q4 2014, CILANSETRON remains the US FDA Preferred Term for this commodity. Cilansetron bears US NLM identifiers UMLS ID C0249289 and NCI Concept Code C76106. SMILES: O=C1C(CCC2N3C4C(C12)CCCC4CCC3)CN1C(NCC1)C.

